E2F1 and diffuse large B-cell lymphoma: Regarding DLBCL cases, high E2F1 expression (>10%) (Figure 4(a)) presented in 44/85 of cases (52%), while low E2F1 expression (≤10%) (Figure 4(b)) presented in 41/85 of cases (48%).